Non-Human Animals Expressing Antibodies Having A Common Light Chain

Patent No. EP2701499 (titled "Non-Human Animals Expressing Antibodies Having A Common Light Chain") was filed by Regeneron Pharmaceuticals on Apr 24, 2012. The application was issued on Aug 18, 2021.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MERUSNov 10, 2016LAHRTZ

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2701499

REGENERON PHARMACEUTICALS
Application Number
EP12717033A
Filing Date
Apr 24, 2012
Status
Patent Maintained As Amended
Jul 16, 2021
Publication Date
Aug 18, 2021